PCRX R&D Expenses
Pacira Biosciences Inc · R&D Expenses
PCRX R&D Expenses
Latest reported$30.24Mperiod ending
PCRX Quarterly R&D Expenses ($5.57M → $30.24M)
Quarterly R&D Expenses
High-resolution chart · PNG
PCRX r&d expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 30,243,000 | |
| 28,072,000 | |
| 37,453,000 | |
| 25,966,000 | |
| 28,200,000 | |
| 25,342,000 | |
| 23,897,000 | |
| 19,104,000 | |
| 20,338,000 | |
| 18,238,000 | |
| 19,463,000 | |
| 20,830,000 | |
| 18,824,000 | |
| 17,140,000 | |
| 17,505,000 | |
| 19,405,000 | |
| 26,282,000 | |
| 21,605,000 | |
| 15,514,000 | |
| 11,578,000 | |
| 12,573,000 | |
| 15,879,000 | |
| 15,331,000 | |
| 14,651,000 | |
| 13,620,000 | |
| 15,819,000 | |
| 19,653,000 | |
| 20,255,000 | |
| 17,827,000 | |
| 14,384,000 | |
| 14,174,000 | |
| 14,897,000 | |
| 12,239,000 | |
| 14,378,000 | |
| 10,028,000 | |
| 11,775,000 | |
| 18,856,000 | |
| 16,632,000 | |
| 17,069,000 | |
| 9,754,000 | |
| 9,362,000 | |
| 9,493,000 | |
| 13,153,000 | |
| 5,893,000 | |
| 3,649,000 | |
| 5,967,000 | |
| 3,886,000 | |
| 4,425,000 | |
| 5,216,000 | |
| 5,204,000 | |
| 4,836,000 | |
| 5,962,000 | |
| 4,857,000 | |
| 5,905,000 | |
| 3,244,000 | |
| 3,527,000 | |
| 1,872,000 | |
| 1,294,000 | |
| 2,636,000 | |
| 4,344,000 | |
| 4,381,000 | |
| 3,513,000 | |
| 3,674,000 | |
| 5,716,000 | |
| 4,596,000 | |
| 4,642,000 | |
| 7,516,000 | |
| 5,570,000 |